FMC (FMC)
(Delayed Data from NYSE)
$63.15 USD
-1.84 (-2.83%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $63.11 -0.04 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.15 USD
-1.84 (-2.83%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $63.11 -0.04 (-0.06%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Zacks News
Don't Overlook FMC (FMC) International Revenue Trends While Assessing the Stock
by Zacks Equity Research
Explore FMC's (FMC) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
FMC's Earnings and Sales Surpass Estimates in Q3 on Higher Volumes
by Zacks Equity Research
FMC benefits from volume growth and lower costs from restructuring actions in the third quarter.
FMC (FMC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
FMC (FMC) delivered earnings and revenue surprises of 40.82% and 3.39%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
JMPLY or FMC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
JMPLY vs. FMC: Which Stock Is the Better Value Option?
FMC to Report Q3 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
FMC is likely to have faced challenges from pricing pressure and significant unabsorbed fixed costs in the third quarter.
Stepan Co. (SCL) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC (FMC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
FMC (FMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FMC Stock Gains on New Products and Cost-reduction Actions
by Zacks Equity Research
FMC benefits from its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.
Zacks Industry Outlook DuPont de Nemours, FMC and Cabot
by Zacks Equity Research
DuPont de Nemours, FMC and Cabot have been highlighted in this Industry Outlook article.
3 Diversified Chemical Stocks to Escape Industry Challenges
by Anindya Barman
Demand softness in specific markets and the slowdown in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, FMC and CBT are poised to navigate the industry challenges.
Best Income Stocks to Buy for October 8th
by Zacks Equity Research
MPLX, FMC and MBCN made it to the Zacks Rank #1 (Strong Buy) income stocks list on October 8, 2024.
FMC vs. AIQUY: Which Stock Is the Better Value Option?
by Zacks Equity Research
FMC vs. AIQUY: Which Stock Is the Better Value Option?
Here's Why You Should Add FMC Stock to Your Portfolio Now
by Zacks Equity Research
FMC gains on its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.
FMC Partners Ballagro to Expand Biologicals Crop Protection in Brazil
by Zacks Equity Research
FMC and Ballagro will be able to offer growers a full suite of biological solutions to boost productivity, efficiency and sustainability.
FMC Stock Rises 18% in 3 Months: What's Driving the Rally?
by Zacks Equity Research
FMC benefits from its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.
Is Invesco S&P 500 Equal Weight Materials ETF (RSPM) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPM
Is First Trust Materials AlphaDEX ETF (FXZ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXZ
Here's Why You Should Hold FMC Stock in Your Portfolio for Now
by Zacks Equity Research
While FMC faces headwinds from pricing and cost pressures, it gains on its efforts to strengthen its product portfolio and restructuring actions.
Should You Invest in the First Trust Materials AlphaDEX ETF (FXZ)?
by Zacks Equity Research
Sector ETF report for FXZ
FMC Shares Rise 10% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
FMC gains on its efforts to expand its product portfolio through new product launches and restructuring and cost-reduction actions.
Should You Invest in the Invesco S&P 500 Equal Weight Materials ETF (RSPM)?
by Zacks Equity Research
Sector ETF report for RSPM
FMC (FMC) Up 1.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
FMC (FMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
FMC Shares Gain 14% in 6 Months: What's Driving the Stock?
by Zacks Equity Research
FMC benefits from its efforts to strengthen its product portfolio through new product launches and its restructuring and cost-reduction program.
Here's Why You Should Retain FMC Stock in Your Portfolio
by Zacks Equity Research
While FMC faces headwinds from pricing and cost pressures, it gains on its efforts to strengthen its product portfolio and restructuring actions.
FMC Submits Regulatory Applications for Dodhylex Active
by Zacks Equity Research
Dodhylex active by FMC is a key improvement for the agriculture industry because it combats resistant grass weeds.